OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Teclistamab: Mechanism of action, clinical, and translational science
Yue Guo, Natalia A. Quijano Cardé, Lijuan Kang, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 7
Yue Guo, Natalia A. Quijano Cardé, Lijuan Kang, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 7
Showing 7 citing articles:
The first case of Teclistamab interference with serum electrophoresis and immunofixation
Kamran Kadkhoda, Beth Faiman, Jason Valent, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2025)
Closed Access
Kamran Kadkhoda, Beth Faiman, Jason Valent, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2025)
Closed Access
Effectiveness and safety of teclistamab for relapsed or refractory multiple myeloma: a systematic review and meta-analysis
Wenze Li, Defeng Zhao, Jiao Yu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Wenze Li, Defeng Zhao, Jiao Yu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Teclistamab Dosing in Responders: Modeling and Simulation Results from the MajesTEC-1 Study in Relapsed/Refractory Multiple Myeloma
Yue Guo, Jin Niu, Natalia A. Quijano Cardé, et al.
Targeted Oncology (2025)
Open Access
Yue Guo, Jin Niu, Natalia A. Quijano Cardé, et al.
Targeted Oncology (2025)
Open Access
The first case of Teclistamab interference with serum electrophoresis and immunofixation
Kamran Kadkhoda, Beth Faiman, Jason Valent, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2024)
Closed Access
Kamran Kadkhoda, Beth Faiman, Jason Valent, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2024)
Closed Access
Application of pharmacometrics in drug development
Yuan Xiong, Mahesh N. Samtani, Danièle Ouellet
Advanced Drug Delivery Reviews (2024), pp. 115503-115503
Closed Access
Yuan Xiong, Mahesh N. Samtani, Danièle Ouellet
Advanced Drug Delivery Reviews (2024), pp. 115503-115503
Closed Access
A Phase 1/2 study of teclistamab, a humanized BCMA × CD3 bispecific Ab in Japanese patients with relapsed/refractory MM
Tadao Ishida, Yoshiaki Kuroda, Kosei Matsue, et al.
International Journal of Hematology (2024)
Open Access
Tadao Ishida, Yoshiaki Kuroda, Kosei Matsue, et al.
International Journal of Hematology (2024)
Open Access
Sequelae of B-Cell Depleting Therapy: An Immunologist’s Perspective
Mark Kačar, Adam Al‐Hakim, Sinisa Savic
BioDrugs (2024)
Closed Access
Mark Kačar, Adam Al‐Hakim, Sinisa Savic
BioDrugs (2024)
Closed Access
